Caplin Point Laboratories Ltd. (CAPLIPOINT): Caplin Point Laboratories Share Price rises 5.18% today
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Caplin Point Laboratories Share Price rose to Rs 2,730 today, up 5.18% from the previous close, while the company’s market capitalisation stood at Rs 19,639.14 crore. In this Caplin Point Laboratories Share Price update, the session shows a clear same-day price rise, but the supplied data does not establish a company-specific catalyst. The move is still relevant because it changes the stock’s short-term market setting and places Caplin Point Laboratories Ltd. back in focus in Caplin Point Laboratories Stock News and broader Indian stock market tracking on Univest.
The stock opened at Rs 2,593.90, matched the day’s low at the same level, and touched Rs 2,760 before settling at Rs 2,730. Turnover for the session was Rs 2.99 crore. For investors scanning Caplin Point Laboratories Share Price Today, the verified facts show a higher close, a wider intraday range and a valuation profile that can be compared with the Healthcare and Pharmaceuticals & Drugs peer set. Univest tracks this type of Caplin Point Laboratories Share Price Rise with a focus on facts first and interpretation second.
Caplin Point Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,730 |
| Previous Close | Rs 2,595.45 |
| Today's Move | Rs 134.55 (+5.18%) |
| Open | Rs 2,593.9 |
| High | Rs 2,760 |
| Low | Rs 2,593.9 |
| Turnover | Rs 2.99 crore |
| Market Capitalisation | Rs 19,639.14 crore |
| Market Cap Category | Mid Cap |
Caplin Point Laboratories Ltd. (CAPLIPOINT) rose to Rs 2,730 from the previous close of Rs 2,595.45, a move of Rs 134.55 or 5.18%. The stock opened at Rs 2,593.9, reached a high of Rs 2,760, recorded a low of Rs 2,593.9.
Caplin Point Laboratories Share Price Today shows a gain of Rs 134.55, or 5.18%, from the previous close of Rs 2,595.45 to Rs 2,730. The day’s range stretched from Rs 2,593.90 to Rs 2,760, with the opening at Rs 2,593.90. That means the stock finished near the upper end of the session, but the supplied data only confirms the price event and does not establish why it happened. For readers following Caplin Point Laboratories Stock News or Caplin Point Laboratories Share Price News, the session stands out because the daily move is sizeable against the prior close and the market capitalisation remains Rs 19,639.14 crore. Univest presents this as a verified Caplin Point Laboratories Share Price Update rather than an inferred story.
Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 19,639.14 crore |
| P/E Ratio | 29.65x |
| P/B Ratio | 5.37x |
| ROE | 20.79% |
| ROCE | 24.97% |
| EPS | Rs 87.53 |
| Book Value Per Share | Rs 483.17 |
| Dividend Yield | 0.31% |
Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P/E 29.65x, P/B 5.37x, ROE 20.79%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.
Caplin Point Laboratories Ltd. has a market capitalisation of Rs 19639.14 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.65x, P/B at 5.37x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 87.53, book value per share of Rs 483.17, dividend yield of 0.31%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.65x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 5.37x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 20.79% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 24.97% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 19,639.14 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 29.65x, which is below the benchmark median of 32.69x, a difference of -9.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 20.79%, which is above the benchmark median of 11.78%, a difference of +76.49%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 24.97%, which is above the benchmark median of 13.65%, a difference of +82.93%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 29.65x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.79% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 19,639.14 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Caplin Point Laboratories
- Caplin Point Laboratories Share Price rose 5.18% today to Rs 2,730, with a day’s gain of Rs 134.55.
- The stock moved between Rs 2,593.90 and Rs 2,760 during the session, giving a defined intraday range for Caplin Point Laboratories Share Price Today.
- Market capitalisation stood at Rs 19,639.14 crore, which places the company above the same-industry median market cap.
- P/E is 29.65, P/B is 5.37, ROE is 20.79% and ROCE is 24.97%, giving Caplin Point Laboratories Fundamental Analysis a clear valuation and profitability base.
- Caplin Point Laboratories Share Price sits against a healthcare peer set where its ROCE is above several large listed peers.
About Caplin Point Laboratories
Caplin Point Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not include a segment or product breakdown, so the company description here is kept to verified market classification and financial profile. The business is part of a broad pharmaceutical universe that includes formulation and branded-drug peers across India’s listed healthcare space.
From an investor’s perspective, Caplin Point Laboratories Share News is shaped here by measurable facts: the company has a market capitalisation of Rs 19,639.14 crore, EPS of Rs 87.53, book value of Rs 483.17 per share and dividend yield of 0.31%. Those figures help place Caplin Point Laboratories Share Price in a wider financial context for readers using Univest to track company-specific stock updates, market cap and fundamental ratios. The company remains part of the broader Indian stock market healthcare basket, where profitability and valuation comparisons are often used together.
Track Caplin Point Laboratories Share Price on Univest
Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Caplin Point Laboratories Share Price rise today?
Ans. The supplied data confirms a 5.18% rise in Caplin Point Laboratories Share Price to Rs 2,730, but it does not establish a company-specific catalyst. The event is still notable because it changed the day’s price range and closing level.
What is Caplin Point Laboratories Share Price today?
Ans. Caplin Point Laboratories Share Price today is Rs 2,730. It was up Rs 134.55 from the previous close of Rs 2,595.45, making it one of the day’s sharper moves in the supplied dataset.
What is Caplin Point Laboratories market capitalisation?
Ans. Caplin Point Laboratories market capitalisation is Rs 19,639.14 crore. That places the company above the same-industry median market cap of Rs 741.38 crore and above the benchmark average of Rs 13,917.82 crore.
How does Caplin Point Laboratories look on valuation?
Ans. Caplin Point Laboratories has a P/E of 29.65 and a P/B of 5.37. Relative to the same-industry median P/E of 32.69, the earnings multiple is lower, while the book multiple is higher than the median of 3.10.
What do Caplin Point Laboratories ROE and ROCE show?
Ans. Caplin Point Laboratories reports ROE of 20.79% and ROCE of 24.97%. Both are above the benchmark medians in the same-industry set, which helps place the company’s return profile in context.
How does Caplin Point Laboratories compare with peers?
Ans. Caplin Point Laboratories’ P/E is below Divi’s Laboratories Ltd. and Torrent Pharmaceuticals Ltd., and its ROCE is above several listed peers. The market cap also sits below the largest healthcare names in the supplied peer set.
Should investors track Caplin Point Laboratories Share Price on Univest?
Ans. Investors can track Caplin Point Laboratories Share Price on Univest for live price updates, financial ratios, shareholding pattern and peer comparisons. The platform keeps the stock story tied to verified market data and sector benchmarks.
